当前位置:首页 - 行情中心 - 恩威医药(301331) - 财务分析

恩威医药

(301331)

  

流通市值:32.81亿  总市值:32.87亿
流通股本:1.03亿   总股本:1.03亿

恩威医药(301331)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.38亿元,每股收益0.38元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益108287.90万元,未分配利润35848.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产151598.48万元,负债43310.58万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入449,221,452.75196,499,491.35812,127,431.13560,341,100.4
营业总成本408,252,811.68183,733,734.69763,172,474.47534,869,746.2
其他经营收益
营业利润45,901,404.718,195,945.0849,686,515.9928,533,339.83
利润总额45,729,439.3917,986,639.7446,683,834.3225,522,582.05
净利润38,344,181.2516,305,126.8937,497,544.3522,021,962.58
每股收益
其他综合收益----
综合收益总额38,344,181.2516,305,126.8937,497,544.3522,021,962.58
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计956,378,438.7942,025,659.66952,037,157.23864,538,310.27
非流动资产:
非流动资产合计559,606,358.59554,244,464.41552,491,760.82558,356,241.46
资产总计1,515,984,797.291,496,270,124.071,504,528,918.051,422,894,551.73
流动负债:
流动负债合计232,562,769.89212,532,003.52238,422,148.41178,024,258.43
非流动负债:
非流动负债合计200,542,991.26207,233,151.98208,435,686.15222,906,155.01
负债合计433,105,761.15419,765,155.5446,857,834.56400,930,413.44
所有者权益(或股东权益):
归属于母公司股东权益合计1,082,879,036.141,076,504,968.571,057,671,083.491,021,964,138.29
股东权益合计1,082,879,036.141,076,504,968.571,057,671,083.491,021,964,138.29
负债和股东权益合计1,515,984,797.291,496,270,124.071,504,528,918.051,422,894,551.73
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计425,210,134.08199,901,802.99749,688,281.63567,084,978.47
经营活动现金流出小计350,027,973.26175,223,677.5670,768,561.8495,620,500.73
经营活动产生的现金流量净额75,182,160.8224,678,125.4978,919,719.8371,464,477.74
投资活动产生的现金流量:
投资活动现金流入小计865,450,815.15422,479,327.18957,717,557.13640,603,505.93
投资活动现金流出小计904,218,278.07442,453,732.731,068,334,929.94654,088,085.94
投资活动产生的现金流量净额-38,767,462.92-19,974,405.55-110,617,372.81-13,484,580.01
筹资活动产生的现金流量:
筹资活动现金流入小计--260,163,611.13241,800,000
筹资活动现金流出小计25,580,789.63828,750175,059,041.11170,167,751.6
筹资活动产生的现金流量净额-25,580,789.63-828,75085,104,570.0271,632,248.4
汇率变动对现金及现金等价物的影响-25.42-8.6990.3-64.32
现金及现金等价物净增加额10,833,882.853,874,961.2553,407,007.34129,612,081.81
期末现金及现金等价物余额300,057,672.4293,098,750.8289,223,789.55365,428,864.02
补充资料:
现金及现金等价物的净增加额10,833,882.85-53,407,007.34-
TOP↑